Endogenous matrix metalloproteinases 2 and 9 regulate activation of CD4+and CD8+ T cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 5, 2011, Pages 700-708

  Benson, Heather L ^a   Mobashery, Shahriar ^b   Chang, Mayland ^b   Kheradmand, Farrah ^c   Hong, Jeong Soo ^c   Smith, Gerald N ^a   Shilling, Rebecca A ^d   Wilkes, David S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Matrix metalloproteinase 2; Matrix metalloproteinase 9; SB 3CT; T cells

Indexed keywords

CALCIUM; GELATINASE A; GELATINASE B; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNOREGULATION; IN VIVO STUDY; LUNG INJURY; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; ANTIGENS, THY-1; CALCIUM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOSUPPRESSIVE AGENTS; LUNG; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL;

MURINAE; MUS;

EID: 79955510601     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0125OC     Document Type: Article

References (42)

1. Greenlee KJ, Corry DB, Engler DA, Matsunami RK, Tessier P, Cook RG, Werb Z, Kheradmand F. Proteomic Identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol 2006;177:7312-7321. (Pubitemid 44715101)
2. Goetzl E, Banda M, Leppert D. Commentary: matrix metalloproteinases in immunity. J Immunol 1996;156:1-4.
3. Nagase H, Woessner JFJ. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494. (Pubitemid 129519680)
4. Rosenblum G, Meroueh S, Toth M, Fisher JF, Fridman R, Mobashery S, Sagi I. Molecular structures and dynamics of the stepwise activation mechanism of a matrix metalloproteinase zymogen: challenging the cysteine switch dogma. J Am Chem Soc 2007;129:13566-13574. (Pubitemid 350071785)
5. Creemers EEJM, Cleutjens JPM, Smits JFM, Daemen MJAP. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 2001;89:201-210.
6. Shapiro SD, Senior RM. Matrix metalloproteinases: matrix degradation and more. Am J Respir Cell Mol Biol 1999;20:1100-1102. (Pubitemid 129503226)
7. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516. (Pubitemid 33096184)
8. Opdenakker G, Van-den-Steen P, Van-Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 2001;22:571-579.
9. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001;69:851-859. (Pubitemid 32577883)
10. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 1990;259:L159-L184. (Pubitemid 20342228)
11. Cosio MG, Guerassimov A. Chronic obstructive pulmonary disease: inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med 1999;160:S21-S25.
12. Belleguic C, Corbel M, Germain N, Léna H, Boichot E, Delaval P, Lagente V. Increased release of matrix metalloproteinase 2 and 9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy 2002;32:217-223. (Pubitemid 34429599)
13. Dell'Agli M, Galli GV, Bosisio E, D'Ambrosio M. Inhibition of NF-kB and metalloproteinase-9 expression and secretion by parthenolide derivatives. Bioorg Med Chem Lett 2009;19:1858-1860.
14. Campbell LG, Ramachandran S, Liu W, Shipley JM, Itohara S, Rogers JG, Moazami N, Senior RM, Jaramillo A. Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection. Am J Transplant 2005;5:517-528. (Pubitemid 40313343)
15. Fernandez FG, Campbell LG, Liu W, Shipley JM, Itohara S, Patterson GA, Senior RM, Mohanakumar T, Jaramillo A. Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency. Am J Transplant 2005;5:671-683. (Pubitemid 40461276)
16. Corry DB, Kiss A, Song L-Z, Song L, Xu J, Lee S-H, Werb Z, Kheradmand F. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J 2004;18:995-997. (Pubitemid 39561503)
17. Graesser D, Mahooti S, Madri JA. Distinct roles for matrix metalloproteinase- 2 and [alpha]4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis. J Neuroimmunol 2000;109:121-131.
18. Yoshida S, Iwata T, Chiyo M, Smith GN, Foresman BH, Mickler EA, Heidler KM, Cummings OW, Fujisawa T, Brand DD, et al. Metalloproteinase inhibition has differential effects on alloimmunity, autoimmunity, and histopathology in the transplanted lung. Transplantation 2007;83:799-808. (Pubitemid 46569200)
19. Shilling RA, Clay BS, Tesciuba AG, Berry EL, Lu T, Moore TV, Bandukwala HS, Tong J, Weinstock JV, Flavell RA, et al. CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo. Cell Immunol 2009;259:177-184.
20. Sumpter TL, Payne KK, Wilkes DS. Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25- helper T cells. J Leukoc Biol 2008;83:708-717. (Pubitemid 351966881)
21. Bobadilla JL, Love RB, Jankowska-Gan E, Xu Q, Haynes LD, Braun RK, Hayney MS, Munoz del Rio A, Meyer K, Greenspan DS, et al. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 2008;177:660-668. (Pubitemid 351442174)
22. Owen JL, Iragavarapu-Charyulu V, Gunja-Smith Z, Herbert LM, Grosso JF, Lopez DM. Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol 2003;171:4340-4351. (Pubitemid 37238712)
23. Leppert D, Waubant E, Galardy R, Bunnett N, Hauser S. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-4389.
24. Montgomery AMSH, Reisfeld RA. Production and regulation of gelatinase B by human T-cells. Biochim Biophys Acta 1993;1176:265-268. (Pubitemid 23113768)
25. Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J Cell Physiol 1993;157:644-649. (Pubitemid 23361195)
26. Zhou H, Bernhard EJ, Fox FE, Billings PC. Induction of metalloproteinase activity in human T-lymphocytes. Biochim Biophys Acta 1993;1177:174-178. (Pubitemid 23169572)
27. Sandler C, Ekokoski E, Lindstedt KA, Vainio PJ, Finel M, Sorsa T, Kovanen PT, Golub LM, Eklund KK. Chemically modified tetracycline (CMT)-3 inhibits histamine release and cytokine production in mast cells: possible involvement of protein kinase C. Inflamm Res 2005;54:304-312. (Pubitemid 41185492)
28. Brown S, Bernardo MM, Li ZH, Kotra LP, Tanaka Y, Fridman R, Mobashery S. Potent and selective mechanism-based inhibition of gelatinases. J Am Chem Soc 2000;122:6799-6800. (Pubitemid 30490016)
29. Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang Z, Bigg HF, Overall CM, DeClerck YA, Tschesche H, Cher ML. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro- MMP-2. J Biol Chem 2000;275:41415-41423. (Pubitemid 32054977)
30. Forbes C, Shi Q, Fisher JF, Lee M, Hesek D, Llarrull LI, Toth M, Gossing M, Fridman R, Mobashery S. Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases. Chem Biol Drug Des 2009;74:527-534.
31. Hall SR, Rhodes J. Schiff base-mediated co-stimulation primes the T-cell-receptor-dependent calcium signalling pathway in CD4 T cells. Immunology 2001;104:50-57.
32. 2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2. J Biol Chem 2004;279:12427-12437.
33. Medoff BD, Seung E, Wain JC, Means TK, Campanella GSV, Islam SA, Thomas SY, Ginns LC, Grabie N, Lichtman AH, et al. BLT1- mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J Exp Med 2005;202:97-110. (Pubitemid 41002913)
34. Stripp B, Sawaya P, Luse D, Wikenheiser K, Wert S, Huffman J, Lattier DL, Singh G, Katyal SL, Whitsett JA. cis-acting elements that confer lung epithelial cell expression of the CC10 gene. J Biol Chem 1992;267:14703-14712.
35. Carbone F, Bevan M. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J Exp Med 1989;169:603-612. (Pubitemid 19085807)
36. Oviedo-Orta E, Bermudez-Fajardo A, Karanam S, Benbow U, Newby AC. Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages. Immunology 2008;124:42-50.
37. Hardison MT, Galin FS, Calderon CE, Djekic UV, Parker SB, Wille KM, Jackson PL, Oster RA, Young KR, Blalock JE, Gaggar A. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. J Immunol 2009;182:4423-4431.
38. Hughes CE, Caterson B, Fosang AJ, Roughley PJ, Mort JS. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J 1995;305:799-804.
39. Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J 2004;18:690-692.
40. Si-Tayeb K, Monvoisin A, Mazzocco C, Lepreux S, Decossas M, Cubel G, Taras D, Blanc JF, Robinson DR, Rosenbaum J. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 2006;169:1390-1401. (Pubitemid 351194372)
41. Lokeshwar BL. MMP inhibition in prostate cancer. Ann NY Acad Sci 1999;878:271-289. (Pubitemid 29353576)
42. Zervos EE, Shafii AE, Rosemurgy AS. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. J Surg Res 1999;81:65-68. (Pubitemid 29393779)